Cargando…
Tumor-intrinsic PIK3CA represses tumor immunogenicity in a model of pancreatic cancer
The presence of tumor-infiltrating T cells is associated with favorable patient outcomes, yet most pancreatic cancers are immunologically silent and resistant to currently available immunotherapies. Here we show using a syngeneic orthotopic implantation model of pancreatic cancer that Pik3ca regulat...
Autores principales: | Sivaram, Nithya, McLaughlin, Patrick A., Han, Han V., Petrenko, Oleksi, Jiang, Ya-Ping, Ballou, Lisa M., Pham, Kien, Liu, Chen, van der Velden, Adrianus W.M., Lin, Richard Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668699/ https://www.ncbi.nlm.nih.gov/pubmed/31112530 http://dx.doi.org/10.1172/JCI123540 |
Ejemplares similares
-
Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data
por: Pan, Yinglian, et al.
Publicado: (2019) -
PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer
por: Kim, Ji-Won, et al.
Publicado: (2017) -
Tumor-intrinsic determinants of immunogenic cell death modalities
por: Workenhe, Samuel T, et al.
Publicado: (2021) -
Direct reprogramming en route to neoplastic transformation
por: Nemajerova, Alice, et al.
Publicado: (2013) -
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
por: Chandran, Smita S., et al.
Publicado: (2022)